Exhibit 107
Calculation of Filing Fee Table
S-1
(Form Type)
Inhibikase Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||||
| Fees to Be Paid | Equity | Common stock issuable upon exercise of warrants | 457(g) | 4,761,904 | $1.68(2) | $7,999,998.70 | 0.00014760 | $1,180.80 | ||||||||
| Total Offering Amounts | $7,999,998.70 | $1,180.80 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $1,180.80 | |||||||||||||||
| (1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of the Registrant’s common stock as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(g) of the Securities Act. The proposed maximum offering price per share is calculated based on the exercise price of the subject warrants. |